Sunzen Biotech Berhad reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was MYR 97.1 million compared to MYR 90.48 million a year ago. Net income was MYR 3.64 million compared to MYR 0.68 million a year ago.

Basic earnings per share from continuing operations was MYR 0.0051 compared to MYR 0.0012 a year ago. Diluted earnings per share from continuing operations was MYR 0.0049 compared to MYR 0.0011 a year ago.